Efficacy and Safety of Neoadjuvant Monoimmunotherapy With PD-1 Inhibitor for dMMR/MSIâH Locally Advanced Colorectal Cancer: A Single-Center Real-World Study.

Zhang, Xuan; Yang, Renfang; Wu, Tao; Cai, Xinyi; Li, Guoyu; Yu, Kun; Li, Yong; Ding, Rong; Dong, Chao; Li, Jinsha; Hu, Ruixi; Feng, Qing; Li, Yunfeng

Efficacy and Safety of Neoadjuvant Monoimmunotherapy With PD-1 Inhibitor for dMMR/MSIâH Locally Advanced Colorectal Cancer: A Single-Center Real-World Study.

Zhang, Xuan; Yang, Renfang; Wu, Tao; Cai, Xinyi; Li, Guoyu; Yu, Kun; Li, Yong; Ding, Rong; Dong, Chao; Li, Jinsha; Hu, Ruixi; Feng, Qing; Li, Yunfeng.

Afiliação

Zhang X; Department of Colorectal surgery, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Kunming, China.
Yang R; Department of Colorectal surgery, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Kunming, China.
Wu T; Department of Colorectal surgery, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Kunming, China.
Cai X; Department of Colorectal surgery, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Kunming, China.
Li G; Department of Colorectal surgery, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Kunming, China.
Yu K; Department of Colorectal surgery, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Kunming, China.
Li Y; Department of Hepatobiliary and Pancreatic Surgery, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Kunming, China.
Ding R; Department of Minimally Invasive Intervention, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Kunming, China.
Dong C; Department of Oncology, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Kunming, China.
Li J; Department of Colorectal surgery, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Kunming, China.
Hu R; Department of Colorectal surgery, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Kunming, China.
Feng Q; Department of Colorectal surgery, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Kunming, China.
Li Y; Department of Colorectal surgery, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Kunming, China.

Front Immunol ; 13: 913483, 2022.

Article em En | MEDLINE | ID: mdl-35958603

Assuntos

Neoplasias do Colo; Terapia Neoadjuvante; China; Reparo de Erro de Pareamento de DNA; Humanos; Inibidores de Checkpoint Imunológico/efeitos adversos; Receptor de Morte Celular Programada 1; Estudos Retrospectivos

Palavras-chave

locally advanced colorectal cancer; microsatellite instability-high (MSI-H); mismatch repair-deficient; neoadjuvant immunotherapy; programmed cell death protein-1 inhibitor

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias do Colo / Terapia Neoadjuvante Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans País como assunto: Asia Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google